Lifen

Lifen

Private
FranceHealthcare & Life Scienceshttps://www.lifen.fr

Last Round

Series C

Nov 16, 2021

Total Funding Raised

$89.91M

Company Overview

Lifen is a French HealthTech company founded in 2015 that develops a healthcare data management platform to streamline medical communication and the digital exchange of documents. The company's solutions connect healthcare providers, hospitals, and patients, aiming to create a 'Healthcare Operating System' that provides instant access to health data and digital innovations. Initially launched as a secure messaging system, Lifen has expanded its offerings to a Platform as a Service (PaaS) model that simplifies the deployment of third-party digital health solutions within hospital information systems. The company is venture-backed, having raised significant funding through multiple rounds, including a Series C in 2021.

Sector

Healthcare & Life Sciences

Verticals

Document Management, Data Integration, Platform-as-a-Service, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Government Contracts

AI Layer

Application

Keywords

medical document exchangesecure medical messaginghealth data interoperabilityhealthcare SaaSEHR integrationhealthtechdigital health platformhospital information system integrationFHIR compatibilitycare coordinationpatient cohort identificationhealthcare operating systemclinical research toolsmedical schedulingusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lifen Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lifen Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CNov 16, 2021
Series BJun 13, 2019
Series AMar 8, 2018

Key People

Founding team and executive leadership

Franck Le Ouay

Co-founder & CEO

Founding Team

Alexandre Heimburger

Chief Technology Officer

Executive Team

Charles Dupuis

CFO

Executive Team

Sacha Vaguelsy

Chief Product Officer

Executive Team

Lifen Investors

Notable investors and investment history

InvestorRounds
PartechSeries C, Series B
Idinvest PartnersSeries B
Lauxera Capital PartnersSeries C
Serena Data VenturesSeries C, Series B
DaphniSeries A, Series B
CreadevSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Manages 40% of medical report exchanges in France.

  • Mar 1, 2026

    Acquired Curecall, a product automating patient follow-up via SMS.

Lifen Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lifen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lifen's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrance
Employee Range174
Year Founded2015
Last FundingNov 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.